rs199473419
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_000238.4(KCNH2):c.209A>G(p.His70Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H70N) has been classified as Uncertain significance.
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.209A>G | p.His70Arg | missense_variant | 2/15 | ENST00000262186.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KCNH2 | ENST00000262186.10 | c.209A>G | p.His70Arg | missense_variant | 2/15 | 1 | NM_000238.4 | P1 | |
KCNH2 | ENST00000532957.5 | n.432A>G | non_coding_transcript_exon_variant | 2/9 | 2 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 08, 2022 | Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies demonstrate a damaging effect on channel trafficking and/or channel function (Chen et al., 1999; Jou et al., 2013; Anderson et al., 2014; Perry et al., 2016); however, some conflicting studies suggest this variant may have little to no effect on these properties (Gianulis et al., 2011; Harley et al., 2012; Perry et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22396785, 22949429, 23303164, 10973849, 15840476, 11854117, 19841300, 19716085, 10187793, 21536673, 26105569, 15051636, 25294783, 22885918, 26958806, 30012873, 22581653, 33729832, 32475984, 25417810) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jan 26, 2021 | PS3, PS4_Moderate, PM1, PM2_Supportingm PP3 - |
Long QT syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 18, 2023 | This sequence change replaces histidine, which is basic and polar, with arginine, which is basic and polar, at codon 70 of the KCNH2 protein (p.His70Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with long QT syndrome (PMID: 10973849, 11854117, 22949429, 25294783; Invitae). ClinVar contains an entry for this variant (Variation ID: 67363). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects KCNH2 function (PMID: 10187793, 21536673, 22396785, 23303164). For these reasons, this variant has been classified as Pathogenic. - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 10, 2020 | The p.H70R variant (also known as c.209A>G), located in coding exon 2 of the KCNH2 gene, results from an A to G substitution at nucleotide position 209. The histidine at codon 70 is replaced by arginine, an amino acid with highly similar properties, and is located in the PAS domain. This alteration has been detected in individuals reported to have long QT syndrome (LQTS) (Kapa S et al. Circulation. 2009;120:1752-60; Westenskow P et al. Circulation. 2004;109:1834-41; Vijayakumar R et al. Circulation. 2014;130:1936-43) and has also been detected in LQTS cohorts for which clinical details were limited or not provided, and reports may overlap (Splawski I et al. Circulation. 2000;102:1178-85; Moss AJ et al. Circulation, 2002;105:794-9; Kapplinger JD et al. Heart Rhythm. 2009;6(9):1297-303; Medlock MM et al. Heart Rhythm. 2012;9:1977-82). In vitro analyses of this alteration have suggested both accelerated rate of channel deactivation in the Xenopus oocyte model, and a rate similar to wild type using HEK293 cells (Chen J et al. J. Biol. Chem. 1999;274:10113-8; Anderson CL et al. Nat Commun. 2014;5:5535; Gianulis EC et al. J Biol Chem. 2011;286:22160-9). Another study using zebrafish reported this alteration to result in reduced cardiac repolarization and reduced ability to rescue knockouts compared to wild type (Jou CJ et al. Circ Res. 2013;112:826-30). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:10187793;PMID:10973849;PMID:11854117;PMID:15051636;PMID:15840476;PMID:19716085;PMID:19841300;PMID:21536673;PMID:22396785). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at